Krystal Biotech (KRYS) Retained Earnings (2016 - 2026)
Krystal Biotech (KRYS) reported Retained Earnings of $80.1 million for Q1 2026, down 92.91% on a YoY basis from $1.1 billion in Q1 2025, and up 231.5% sequentially from $24.2 million in Q4 2025.
Krystal Biotech (KRYS) Retained Earnings (2016 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 11 years of Retained Earnings data on file, last reported at $80.1 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 92.91% year-over-year to $80.1 million; the trailing twelve-month figure through Mar 2026 stood at $80.1 million (down 92.91% YoY), and the FY2025 full-year result was $24.2 million, up 12817.37% from the prior year.
- Retained Earnings improved to $80.1 million in Q1 2026, from $24.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.1 billion in Q1 2025 to a low of -$326.1 million in Q1 2023.
- A 5-year average of $313.9 million and a median of -$190000.0 in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 136.84% in 2022 and soared 377765.22% in 2025, its largest moves.
- Tracing KRYS's Retained Earnings over 5 years: stood at $803.7 million in 2022, then soared by 30.37% to $1.0 billion in 2023, then tumbled by 100.02% to -$190000.0 in 2024, then surged by 12817.37% to $24.2 million in 2025, then jumped by 231.5% to $80.1 million in 2026.
- Business Quant data shows KRYS's Retained Earnings at $80.1 million in Q1 2026, $24.2 million in Q4 2025, and -$27.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 80.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.10 Mn |
| Dec 31, 2025 | 24.16 Mn |
| Sep 30, 2025 | -27.24 Mn |
| Jun 30, 2025 | -106.60 Mn |
| Mar 31, 2025 | 1.13 Bn |
| Dec 31, 2024 | -190,000.00 |
| Sep 30, 2024 | 1.11 Bn |
| Jun 30, 2024 | -253.33 Mn |
| Mar 31, 2024 | -299,000.00 |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | -326.10 Mn |
| Dec 31, 2022 | 803.72 Mn |
| Sep 30, 2022 | -1.48 Mn |
| Jun 30, 2022 | -1.55 Mn |
| Mar 31, 2022 | -190.70 Mn |
| Dec 31, 2021 | -140.78 Mn |
| Sep 30, 2021 | -118.98 Mn |
| Jun 30, 2021 | -103.39 Mn |